Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
gilead sciences
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
abbvie
allergan aesthetics
alzheimer's disease
amgen
archive
astrazeneca
athira pharma
attralus
biobucks
biontech
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
calistoga pharmaceuticals
cancer
cancer drugs
car-t immunotherapy
checkpoint inhibitors
chiesi farmaceutici
cholestatic liver diseases
click therapeutics
coronavirus
covid-19
cullinan oncology
cystic fibrosis
daniel o'day
deals
detroit blog main
detroit top stories
What
drug
3
×
gilead
3
×
sciences
ceo
pipeline
acquisitions
adding
addressed
answers
bets
big
biggest
bio
boost
build
buy
cancer
company’s
cost
covid
daniel
debut
dyne’s
early
expensive
far
hasten
indicated
medicine
microbiome
million
moves
openly
o’day
paying
positive
program
question
recove
remdesivir
Language
unset
Current search:
gilead
×
drug
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@slashgear.com
3 years ago
Gilead CEO answers big COVID-19 question: How much will remdesivir cost
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
